Zobrazeno 1 - 10
of 706
pro vyhledávání: ''
Autor:
A. du Bois, Jalid Sehouli, David S.P. Tan, Jonathan A. Ledermann, Thaïs Baert, Dearbhaile M. O'Donnell, Antonio González-Martín, Annamaria Ferrero, P. Blecharz, Nicoletta Colombo, Florence Joly, J. van der Velden, Denis Querleu
Publikováno v:
Annals of Oncology. 32:710-725
Treatment approaches for relapsed ovarian cancer have evolved over the past decade from a calendar-based decision tree to a patient-oriented biologically driven algorithm. Nowadays, platinum-based chemotherapy should be offered to all patients with a
Autor:
Khê Hoang-Xuan, Emmanuel Gyan, M Le Garff-Tavernier, Valérie Touitou, F. Morschhauser, Vassili Soumelis, M. Chevrier, O Chinot, M. Laadhari, Hervé Ghesquières, Anna Schmitt, Sylvain Choquet, Cécile Moluçon-Chabrot, I. Turbiez, Nathalie Cassoux, Carole Soussain, Patrick Beauchesne, E. Nicolas-Virelizier, Caroline Houillier, A. Savignoni, Remy Gressin
Publikováno v:
Annals of Oncology. 30:621-628
Background Primary central nervous system lymphomas (PCNSLs) are mainly diffuse large B-cell lymphomas (DLBCLs) of the non-germinal center B-cell (non-GCB) subtype. This study aimed to determine the efficacy of rituximab plus lenalidomide (R2) in DLB
Autor:
Aleksander Giwercman, Gabriella Cohn-Cedermark, Helena Johansson, Stefan Arver, Jakob Eberhard, K. Sandberg, Carina Nord, K. Weibring, Olof Ståhl
Publikováno v:
Annals of Oncology. 30:604-611
BACKGROUND: Little is known regarding sperm production following adjuvant treatment in testicular cancer (TC) clinical stage I (CS I) patients. PATIENTS AND METHODS: A total of 182 TC patients aged 18-50 years were prospectively included during 2001-
Autor:
G.L. De Salvo, G. Moretti, Patricia Galván, Maria Vittoria Dieci, Giancarlo Bisagni, R. Vicini, Gaia Griguolo, Giulia Bianchi, Aleix Prat, Massimo Ambroggi, Tomás Pascual, Laia Paré, Loredana Urso, Antonio Frassoldati, Carlo Alberto Giorgi, Pierfranco Conte, Enrico Orvieto, Valentina Guarneri
Publikováno v:
Annals of Oncology
Background In human epidermal growth factor receptor 2 (HER2+) breast cancers, neoadjuvant trials of chemotherapy plus anti-HER2 treatment consistently showed lower pathologic complete response (pCR) rates in hormone receptor (HR) positive versus neg
Publikováno v:
Annals of Oncology. 32:S148-S149
Autor:
Z-M Shao, Suhui Zhang, Wentao Yang, Ju-Bo Zhang, Junning Cao, Ying Lin, Zhonghua Tao, X. C. Hu, Leiping Wang, Junlong Wu, Jianfeng Luo, X J Sun, Biyun Wang, Zhong Hua Wang
Publikováno v:
Annals of Oncology. 29:1741-1747
Background CBCSG006 trial reported the superior efficacy of cisplatin plus gemcitabine (GP) regimen than paclitaxel plus gemcitabine (GT) regimen as first-line treatment of metastatic triple-negative breast cancer (mTNBC). This study focused on the u
Autor:
John M. Truelson, Xian Jin Xie, Larry L. Myers, Randall S. Hughes, I. Smith, Pierre Lavertu, Baran D. Sumer, Stuart J. Wong, D. Wang, Min Yao, Vasu Tumati, Lucien A. Nedzi, Musaddiq J. Awan
Publikováno v:
Annals of Oncology. 29:998-1003
Background The optimal regimen of chemotherapy and reirradiation (re-XRT) for recurrent head and neck squamous cell carcinoma (HNSCC) is controversial. We report the final outcomes of a multicenter phase II trial evaluating cetuximab and cisplatin-ba
Autor:
Gerald W. Prager, S. Moreno Vera, Dirk Arnold, Nadjat Mounedji, Julien Taieb, Antonio Quintela, Alexander Stein
Publikováno v:
Annals of Oncology
Background The optimal chemotherapeutic regimen for use beyond the second line for patients with metastatic colorectal cancer (mCRC) remains unclear. Materials and methods We systematically searched the Cochrane Database of Systematic Reviews, EMBASE
Autor:
Yolanda I. Garces, Kenneth W. Merrell, Adam C. Amundson, Courtney N. Day, R.W. Gao, Anastasios Dimou, Pranitha Prodduturvar, A.L. Stockham, Dawn Owen, Konstantinos Leventakos, T.K. McKone, Julian R. Molina, S. James, R.S. Smith, Aaron S. Mansfield, Z. Wilson, William S. Harmsen, Kenneth R. Olivier, L. Ng
Publikováno v:
Annals of Oncology. 32:S942
Autor:
L. Shen, Yoshinori Kawaguchi, K. Shitara, J. Tabernero, J. Seraj, Takahiro Kamio, G. Meinhardt, F.A. Franke
Publikováno v:
Annals of Oncology. 32:S1073